Requirement of the transmembrane semaphorin Sema4C for myogenic differentiation  by Ko, Ji-Ae et al.
FEBS Letters 579 (2005) 2236–2242 FEBS 29445Requirement of the transmembrane semaphorin Sema4C
for myogenic diﬀerentiation
Ji-Ae Koa, Toshikazu Gondob, Shinobu Inagakic, Makoto Inuia,*
a Department of Pharmacology, Yamaguchi University School of Medicine, Yamaguchi University Hospital, Ube, Yamaguchi 755-8505, Japan
b Department of Surgical Pathology, Yamaguchi University Hospital, Ube, Yamaguchi 755-8505, Japan
c Group of Neurobiology, School of Allied Health Sciences, Faculty of Medicine, Osaka University, Suita-shi, Osaka 565-0871, Japan
Received 6 January 2005; revised 3 March 2005; accepted 3 March 2005
Available online 22 March 2005
Edited by Ned ManteiAbstract Semaphorins constitute a large family of signaling
proteins that contribute to axonal guidance. Here we demonstrate
that the transmembrane semaphorin Sema4C is up-regulated
both in the early stage of diﬀerentiation of C2C12 mouse skeletal
myoblasts into myotubes and during injury-induced muscle regen-
eration in vivo. Depletion of Sema4C in C2C12 cells resulted in
marked attenuation of myotube formation. A fusion protein con-
taining the extracellular Sema domain and a peptide correspond-
ing to the intracellular COOH-terminal region of Sema4C each
inhibited the diﬀerentiation of C2C12 cells. These ﬁndings indi-
cate that Sema4C-mediated interaction among myoblasts plays
an important role in terminal myogenic diﬀerentiation.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Myogenic diﬀerentiation is a highly orchestrated and multi-
step process [1]. During terminal myogenic diﬀerentiation,
myoblasts exit the cell cycle, increase their expression of myo-
genic transcription factors such as MyoD and myogenin, and
then form multinucleated myotubes and initiate the expression
of myoﬁbrillar proteins such as myosin heavy chain (MHC)
[2,3]. In addition to myogenic transcription factors, several
proteins including integrins [4] and cadherin [5] have been
implicated in regulation of terminal myogenic diﬀerentiation.
Members of the semaphorin family regulate axonal guidance
in the developing nervous system [6]. They include both se-
creted and membrane-bound molecules, the common struc-
tural feature being the presence of an extracellular Sema
domain that comprises a stretch of 500 amino acids. Among
vertebrate transmembrane semaphorins, Sema4B [7] and Se-
ma4C [8] possess a PSD-Dlg-ZO-1 (PDZ) domain-binding mo-
tif in their cytoplasmic COOH-terminal regions. Semaphorins
elicit intracellular responses through their receptors, which
include neuropilins and plexins [9,10], whereas Sema4B andAbbreviations:MHC, myosin heavy chain; PDZ, PSD-Dlg-ZO-1; DM,
diﬀerentiation medium; GST, glutathione S-transferase
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doi:10.1016/j.febslet.2005.03.022Sema4C are also thought to mediate intracellular signaling
through interaction with a PDZ domain-containing protein.
In addition to neuronal development, semaphorins have
been implicated in processes such as organogenesis and im-
mune responses [11,12]. We have now examined the role of Se-
ma4C in myogenic diﬀerentiation of myoblasts into myotubes
with the use of the mouse skeletal muscle C2C12 cell line. We
show that Sema4C-mediated intercellular interaction among
myoblasts is required for terminal myogenic diﬀerentiation.2. Materials and methods
2.1. Cell culture
C2C12 cells were maintained in growth medium, comprising
DMEM supplemented with 20% fetal bovine serum. Diﬀerentiation
of the myoblasts into myotubes was induced by switching the culture
medium to the diﬀerentiation medium (DM), consisting of DMEM
supplemented with 2% horse serum.
2.2. RNAi
Control and Sema4C mRNA-speciﬁc siRNAs were obtained from
Qiagen (Valencia, CA) in duplex form. The target sequences were
as follows: Cont-siRNA, 5 0-AATTCTCCGAACGTGTCACGT-3 0
Sema-siRNA-1, 50-GCGGATGAATTACGACGGAAA-30; and Sema-
siRNA-2, 5 0-CAGGACCTGCCTGCAGAACAA-3 0. C2C12 cells in
24-well plates were transfected with siRNAs (1 lg per well) with
the use of RNAiFect (Qiagen); the ﬁrst transfection was performed
when the cells had achieved 50–60% conﬂuence, and second and
third transfections were performed at intervals of 24 h (when the
cells were 70–80% and 100% conﬂuent, respectively). The second
and third transfections were performed in DM.
2.3. Immunoﬂuorescence analysis
C2C12 cells were grown on 15-mm cover glasses coated with 0.2%
gelatin and were ﬁxed for 15 min with 4% paraformaldehyde. The cells
were permeabilized with 0.5% Triton X-100, incubated for 30 min with
1% bovine serum albumin, and then exposed consecutively to a mouse
monoclonal antibody to skeletal muscle MHC (Sigma, St. Louis, MO)
and Alexa Fluor 488-conjugated goat antibodies to mouse immuno-
globulin G (Molecular Probes, Eugene, OR). In some experiments,
the cells were double stained with DAPI.
2.4. RT-PCR
The PCR protocol was designed to maintain ampliﬁcation in the
exponential phase. The sequences of the PCR primers were as follows:
Sema4C sense, 5 0-CACCCGGCGACTTCGAGAAGAGCTAGAAA-
3 0; Sema4C antisense, 5 0-TCATACTGAAGACTCCTCTGGGTTG-
3 0; MyoD sense, 5 0-GATGGCATGATGGATTACAGC-3 0; MyoD
antisense, 5 0-GACTATGTCCTTTCTTTGGGG-30; myogenin sense,
5 0-GCTCAGCTCCCTCAACCAG-3 0; myogenin antisense, 5 0-ATGT-
GAATGGGGAGTGGGGA-3 0; G3PDH (internal control) sense,
5 0-ACCACAGTCCATGCCATCAC-3 0; G3PDH antisense, 5 0-TCC-blished by Elsevier B.V. All rights reserved.
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GTATGAGAGCTGACT-3 0; Sema4B antisense, 5 0-GTGGCTATG-
TTGTAGTCTTCCTTGT-3 0.
2.5. Preparation of Sema4C fusion proteins and synthetic peptides
Complementary DNAs encoding the Sema (amino acids 46–489),
Psi-repeat (490–562), and Ig (564–665) domains of mouse Sema4C
were cloned into pDEST15 (Invitrogen, Carlsbad, CA). The resulting
plasmids were introduced into Escherichia coli BL21-AI, and expres-
sion of the GST fusion proteins was induced by 0.2% L-arabinose.
The recombinant proteins were then puriﬁed with the use of glutathi-
one–Sepharose beads (Amersham, Piscataway, NJ).
Peptides were synthesized by Genemed Synthesis (South San Fran-
cisco, CA) and puriﬁed by high-performance liquid chromatography.
The peptides contained a modiﬁed TAT sequence (YARAAARQ-
ARA) [13] followed by the COOH-terminal sequence of Sema4C
(QPLPDSNPEESSV) (TAT-W) or by a corresponding mutated se-
quence (QPLPDSNPEEASA) (TAT-M).
2.6. Muscle regeneration model
Mice (BALB/c, 12 weeks old) were anesthetized by intraperitoneal
injection of pentobarbital. Injury and regeneration of skeletal muscle
were induced by intramuscular injection of 400 ll of 10 lM cardio-
toxin (Latoxan, Valence, France) into the hind limbs, as described pre-
viously [14]. Treated muscles were examined before and at various
times after injury, with three animals per time point. These experiments
were approved by the Animal Ethics Committee of Yamaguchi Uni-
versity School of Medicine.3. Results
3.1. Up-regulation of Sema4C during myogenic diﬀerentiation of
C2C12 cells
The diﬀerentiation of C2C12 myoblasts into myotubes was
induced by removal of growth factors from the culture med-
ium. Abundant myotubes were observed 5 days after switch-
ing to DM (Fig. 1A). Immunoblot and RT-PCR analyses
revealed the presence of small amounts of Sema4C protein
(Fig. 1B) and Sema4C mRNA (Fig. 1C) in C2C12 cells be-
fore the induction of diﬀerentiation. The expression of Se-Fig. 1. Expression of Sema4C during diﬀerentiation of C2C12 myoblasts in
diﬀerentiate by culture in DM. Phase-contrast microscopic images of the cell
with antibodies to MHC at 5 days after induction of diﬀerentiation are sho
induction of diﬀerentiation were subjected to immunoblot analysis with antib
the indicated times after induction of diﬀerentiation was subjected to RT-PCma4C was up-regulated at both the protein and mRNA
levels after transfer of the cells to DM. The up-regulation
of Sema4C expression occurred before that of myogenin
expression and concomitantly with that of MyoD expression
(Fig. 1B and C). The expression of Sema4C subsequently de-
creased as mature myotubes formed. We analyzed the
expression of Sema4B by RT-PCR only, given that speciﬁc
antibodies are not available. Sema4B mRNA was detected
in myoblasts, but its abundance was not aﬀected by the
induction of diﬀerentiation (Fig. 1C).3.2. Depletion of Sema4C by RNAi inhibits myotube formation
To clarify the role of Sema4C in terminal myogenic diﬀeren-
tiation, we examined the eﬀects of its depletion by RNA inter-
ference (RNAi). Transfection of C2C12 myoblasts with either
of two diﬀerent small interfering RNAs (Sema-siRNA-1,
Sema-siRNA-2) speciﬁc for Sema4C mRNA resulted in signif-
icant inhibition of myotube formation and MHC expression
(Fig. 2A and B). A control siRNA had no such eﬀects. Immu-
noblot analysis revealed that both Sema4C siRNAs, but not
the control siRNA, largely blocked the up-regulation of Se-
ma4C (Fig. 2C and D). The two Sema4C siRNAs also inhib-
ited the increase in the expression of myogenin, but not that
in the abundance of MyoD (Fig. 2C and D). The transcrip-
tional activity of MyoD was not signiﬁcantly changed by the
Sema4C siRNAs (data not shown) when examined by a lucif-
erase assay using the MyoD-dependent reporter 4Rtk-luc
(kindly provided by Dr. A. Lassar, Harvard Medical School),
which contains four tandem E boxes from the muscle creatine
kinase enhancer upstream of the thymidine kinase basal pro-
moter [15]. These two Sema4C siRNAs have no signiﬁcant ef-
fect on the expression of Sema4B when analyzed by RT-PCR
(data not shown). On the other hand, overexpression of
Sema4C in myoblasts with the use of an adenoviral vector
had no marked eﬀect on the diﬀerentiation of myoblasts into
myotubes (data not shown).to myotubes. (A) C2C12 myoblasts (>70% conﬂuent) were induced to
s at 0, 3, and 5 days as well as an immunoﬂuorescence image obtained
wn. Bar, 25 lm. (B) Cell lysates prepared at the indicated times after
odies to the indicated proteins. (C) Total RNA prepared from cells at
R analysis of the indicated mRNAs.
Fig. 2. Eﬀects of Sema4C depletion on the diﬀerentiation of myoblasts. (A) C2C12 cells were transfected with a control siRNA (Cont-siRNA) or
with either of two siRNAs speciﬁc for Sema4C mRNA (Sema-siRNA-1, Sema-siRNA-2) and were induced to diﬀerentiate by culture in DM. The
cells were examined by phase-contrast microscopy (upper panels) or subjected to immunoﬂuorescence analysis with antibodies to MHC (lower
panels) 5 days after induction of diﬀerentiation. Bar, 25 lm. (B) Nuclei were visualized with DAPI. The percentage of nuclei in MHC-positive cells in
each of 10 randomly chosen ﬁelds (magniﬁcation 200·) was determined at this time to quantify myotube formation. Data are means ± S.E. from a
representative experiment; \P < 0.001 versus the value for cells transfected with the control siRNA. (C) Cell lysates were subjected to immunoblot
analysis at the indicated times after induction of diﬀerentiation. (D) The expression of each protein was quantiﬁed by scanning blots similar to those
shown in (C) was normalized by the expression level of tubulin, and was expressed as a percentage of the maximum normalized value. Data are
means ± S.E. from three independent experiments; \P < 0.01, \\P < 0.001 compared with the value for cells transfected with the control siRNA.
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myogenic diﬀerentiation
The extracellular region of Sema4C contains Sema, Psi-re-
peat, and immunoglobulin domains. We then examined the
possible eﬀects of GST fusion proteins containing each of these
domains individually (GST-Sema, GST-Psi, GST-Ig) on
C2C12 diﬀerentiation. The addition of GST-Sema, but not
that of GST, GST-Psi, or GST-Ig, to DM inhibited both the
formation of myotubes (Fig. 3A and B) and the up-regulationof myogenin (Fig. 3C and D), without aﬀecting the expression
of Sema4C (Fig. 3C and D). These eﬀects of GST-Sema were
thus likely attributable to a dominant negative action.
3.4. Role of the intracellular COOH-terminus of Sema4C in
myogenic diﬀerentiation
Given that Sema4C has a PDZ domain-binding motif (SSV)
at its cytoplasmic COOH-terminus, we next examined whether
the interaction of this motif with a PDZ domain-containing
Fig. 3. Inhibition of myoblast diﬀerentiation by a fusion protein containing the extracellular Sema domain of Sema4C. (A) C2C12 cells were cultured
in the absence (control) or presence of GST, GST-Sema, GST-Psi, or GST-Ig (2.5 lg/ml) for 5 days after the induction of diﬀerentiation. The cells
were then immunostained with antibodies to MHC. Bar, 25 lm. (B) Nuclei were visualized with DAPI. The percentage of nuclei in MHC-positive
cells in each of 10 randomly chosen ﬁelds (magniﬁcation, 200·) was determined at this time to quantify myotube formation. Data are means ± S.E.
from a representative experiment; \P < 0.001 versus control. (C) Cell lysates were subjected to immunoblot analysis at the indicated times after
induction of diﬀerentiation. (D) The expression of each protein was quantiﬁed by scanning blots similar to those shown in (C) was normalized by the
expression level of tubulin, and was expressed as a percentage of the maximum normalized value. Data are means ± S.E. from three independent
experiments; *P < 0.05, \\P < 0.01 versus GST.
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myoblast diﬀerentiation. We exposed C2C12 myoblasts to a
synthetic peptide (TAT-W) containing the COOH-terminal
13 amino acids of Sema4C linked to a modiﬁed TAT sequence
of 11 amino acids that mediates the transport of heterologous
peptides into mammalian cells [13]. The addition of this pep-
tide to DM inhibited the formation of myotubes (Fig. 4A
and B) but it had no marked eﬀect on the expression of Se-
ma4C or myogenin (Fig. 4C). A control peptide (TAT-M) in
which the PDZ domain-binding motif was mutated (ASA)
had no eﬀect on the diﬀerentiation of C2C12 cells (Fig. 4).
These results thus implicated the PDZ domain-binding motif
of Sema4C in myogenic diﬀerentiation.3.5. Up-regulation of Sema4C during injury-induced muscle
regeneration in vivo
To determine whether Sema4C participates in skeletal mus-
cle diﬀerentiation in vivo, we examined its expression in a
mouse model of muscle regeneration [14,16]. Muscle damage
was induced by intramuscular injection of cardiotoxin, and in-
jury-induced muscle regeneration was monitored morphologi-
cally. As shown in Fig. 5A, regeneration was proceeding
normally. As described previously [16], MyoD and myogenin
were undetectable in uninjured muscle but were detected 3
days after injury, gradually returning to basal levels thereafter
(Fig. 5B). Although Sema4C was expressed at a low level be-
fore injury, its abundance was also markedly increased 3 days
Fig. 4. Inhibition of myoblast diﬀerentiation by a synthetic peptide
containing the COOH-terminal region of Sema4C. (A) C2C12 cells
were cultured in the presence of a synthetic peptide containing wild-
type (TAT-W) or mutated (TAT-M) versions of the COOH-terminal
sequence of Sema4C (10 lM) for 24 h before and for 4 days after the
induction of diﬀerentiation by culture in DM. The cells were then
immunostained with antibodies to MHC. Bar, 25 lm. (B) Nuclei were
visualized with DAPI. The percentage of nuclei in MHC-positive cells
in each of 10 randomly chosen ﬁelds (magniﬁcation, 200·) was
determined to quantify myotube formation. Data are means ± S.E.
from a representative experiment; \P < 0.001 versus the corresponding
value for cells treated with TAT-M. (C) Cell lysates prepared 4 days
after the induction of diﬀerentiation were subjected to immunoblot
analysis.
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thus suggest that Sema4C contributes to terminal myogenic
diﬀerentiation in vivo.4. Discussion
The transmembrane semaphorin Sema4C is expressed in a
wide variety of tissues in a developmentally regulated man-ner [8]. However, the functions of this protein have re-
mained unknown. We have now shown that both the early
stage of diﬀerentiation of C2C12 mouse skeletal myoblasts
into myotubes and injury-induced muscle regeneration in
vivo are accompanied by up-regulation of Sema4C. The dif-
ferentiation-associated increase in the expression of Sema4C
in C2C12 cells precedes that of the myogenic transcription
factor myogenin. The inhibitory eﬀects both of Sema4C
depletion by RNAi and of a GST fusion protein containing
the extracellular Sema domain of Sema4C revealed that Se-
ma4C signaling contributes to the induction of myogenin
expression and myotube formation in C2C12 cells. Sema4C
thus plays an essential role in the early steps of myogenic
diﬀerentiation of myoblasts into myotubes. The regeneration
of skeletal muscle after injury occurs by a process that is
highly similar to embryonic muscle diﬀerentiation [17]. The
up-regulation of Sema4C as well as MyoD and myogenin
observed during injury-induced muscle regeneration suggests
that induction of myogenin expression and myotube forma-
tion by Sema4C occurs not only in cultured cells but also
in vivo.
Members of two protein families, plexins and neuropilins,
function as receptors to mediate the actions of semaphorins
in axon guidance [9,10]. Plexins alone are able to bind mem-
brane-bound semaphorins, whereas plexin–neuropilin com-
plexes act as high-aﬃnity receptors for secreted semaphorins.
The signaling pathway downstream of plexins is largely un-
known, although small GTPases and tyrosine phosphorylation
have been implicated in growth cone collapse [10]. Although
the receptor responsible for mediating the action of Sema4C
in terminal myogenic diﬀerentiation remains to be identiﬁed,
our results clearly demonstrated that the intercellular interac-
tion of myoblasts mediated by Sema4C through the Sema
domain plays a key role in terminal myogenic diﬀerentiation
by up-regulating myogenin.
Transmembrane semaphorins are thought to mediate
bidirectional signaling [18]. Our results now indicate that
outside-in signaling by Sema4C through its intracellular
COOH-terminus is also important for terminal myogenic dif-
ferentiation. This signaling through the COOH-terminus of
Sema4C does not aﬀect the induction of myogenin, however,
whereas signaling by the extracellular Sema domain through
its receptor controls the expression of myogenin. Interaction
of Sema4C with the PDZ domains of PSD-95 family proteins
is thought to occur in the brain [19]. Association of Sema4C
with the PDZ domain-containing proteins SEMCAP1 (GIPC)
and SEMCAP2 has also been suggested [20]. The putative
PDZ domain-containing protein that interacts with the
COOH-terminus of Sema4C as well as the downstream signal-
ing proteins in myoblasts await identiﬁcation.
A GST fusion protein containing the Sema domain of Se-
ma4C inhibited both the formation of myotubes and the up-
regulation of myogenin, probably by competing with Sema4C
for its receptor. Disulﬁde bonds in the extracellular region of
semaphorins are thought to be essential for the structure and
biological activity of these proteins [21–23]. The GST-Sema fu-
sion protein used in the present study was expressed in E. coli
and therefore might not be expected to contain the normal pat-
tern of disulﬁde bonds. Although it was not able to reproduce
the activity of Sema4C in C2C12 cells, likely because of an im-
proper conformation, GST-Sema was able to inhibit the inter-
action between Sema4C and its receptor at relatively high
Fig. 5. Expression of Sema4C during regeneration of damaged mouse skeletal muscle. (A) Muscle injury and regeneration were induced by
intramuscular injection of cardiotoxin into the hind limb, and sections of muscle isolated before or 1, 3, 5, or 9 days after injury were stained with
hematoxylin–eosin. Bar, 50 lm. (B) Homogenates of muscles isolated at the indicated times after injury were subjected to immunoblot analysis.
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Sema used in our experiments was 30 nM, the aﬃnity of
the transmembrane semaphorin Sema4D for its plexin receptor
was previously found to be 0.9 nM [24].
Cell adhesion molecules including cadherins [5,25–31] as well
as immunoglobulin superfamily members such as CDO and
BOC [32–34] play important roles in skeletal muscle myogen-
esis. The eﬀects of Sema4C in myoblasts revealed in the present
study are similar to those of cadherins. Cadherin-mediated
adhesion promotes the formation of adherens junctions, the
recruitment of b-catenin to sites of cell–cell contact, and the
induction of myogenin expression and myotube formation.
Both cadherins [5] and Sema4C increase myogenin expression
independently of MyoD, whereas CDO does not aﬀect myog-
enin expression [32]. Both Sema4C and b-catenin also contain
a PDZ domain-binding motif in their COOH-terminal regions.
It will thus be of interest to examine the localization of Se-
ma4C in myoblasts in relation to that of adherens junctions.
The available antibodies to Sema4C are not suitable for immu-
nostaining, however. Recently, the axon guidance molecule ne-
trin and its receptor, neogenin, were shown to stimulate
myotube formation [34]. Cadherins and immunoglobulin
superfamily members including CDO, BOC, and neogenin to-
gether with its ligand netrin have been proposed to form a
large complex at the cell surface [34,35]. It is possible that Se-
ma4C and its associated proteins are also components of this
complex.Acknowledgments: This work was supported in part by grants from the
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